PRP Therapy: The Complete Guide
Table of Contents
- What Platelet-Rich Plasma Therapy Is
- The Centrifuge Process: How Platelet Concentration Works
- Conditions Treated With PRP: 8 Primary Applications
- Who Is a Candidate for PRP Therapy
- What to Expect: 6 Steps From Blood Draw to Recovery
- Results and Realistic Expectations
- Costs and What Is Included
- The Rebuild Regen Approach to PRP
- Is PRP the Right Starting Point or Is a Biologic Upgrade Needed?
- Frequently Asked Questions
- When PRP Is Insufficient and a Stronger Biologic Is Indicated
What Platelet-Rich Plasma Therapy Is
Platelet-rich plasma therapy is an autologous regenerative procedure that concentrates platelets from a patient's own blood, typically 5x to 10x baseline concentration, and reintroduces them into an injury site to accelerate tissue repair using the body's own growth factors.
The word "autologous" is the first defining characteristic: the biologic material comes entirely from the patient's own blood. There is no donor, no external biologic product, and no concern about compatibility or rejection. PRP uses the patient's own regenerative chemistry, concentrated and delivered precisely where it is needed.
Platelets are best known for their role in blood clotting. But platelets carry far more than clotting proteins. Their alpha granules contain a library of growth factors including platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), transforming growth factor-beta (TGF-beta), epidermal growth factor (EGF), and insulin-like growth factor (IGF-1). These proteins are the molecular signals that initiate and coordinate tissue repair following injury.
In a normal injury response, platelets rush to the damaged site and release these factors as part of the healing cascade. The problem is that this natural response is brief and limited by the concentration of platelets available in normal blood (approximately 150,000 to 400,000 per microliter). PRP therapy amplifies this signal by concentrating the platelet count to 5 to 10 times the baseline level before delivering it directly to the target tissue.
Elizabeth Celestin, APRN, FNP-C, administers PRP therapy at Rebuild Regen Medical Clinic as a standalone treatment and as a component of combined regenerative protocols with DayZero™ biologics.
The Centrifuge Process: How Platelet Concentration Works
The quality and potency of platelet-rich plasma is determined by the centrifuge process. Not all PRP is created equal. The specific concentration ratio achieved by centrifugation determines the biological activity of the product delivered to the patient.
Step 1: Blood Draw Standard venous blood draw from the patient's arm. Volume typically 20 to 60 mL depending on the protocol. No anesthesia required.
Step 2: Anticoagulation The blood is drawn into tubes containing an anticoagulant (sodium citrate or ACD-A) to prevent premature clotting before processing. Platelet activation at this stage would reduce the product's potency.
Step 3: First Centrifuge Spin (Soft Spin) The blood is centrifuged at a lower speed to separate red blood cells from the plasma layer. The denser red blood cells fall to the bottom; the lighter platelet-rich plasma and platelet-poor plasma form layers above.
Step 4: Second Centrifuge Spin (Hard Spin) The separated plasma is centrifuged at higher speed to concentrate the platelets. The result is a pellet of concentrated platelets at the bottom of the tube and a supernatant of platelet-poor plasma above. The platelet-poor plasma is removed, and the platelet pellet is resuspended in the remaining small volume of plasma.
Step 5: Leukocyte Decision The provider determines whether to use leukocyte-rich PRP (L-PRP) or leukocyte-poor PRP (P-PRP). This decision affects the inflammatory profile of the product:
- L-PRP contains white blood cells and is used for conditions where the inflammatory response aids the healing process (tendons, muscles, surgical sites).
- P-PRP has white blood cells removed and is preferred for intra-articular injections (joint spaces) where avoiding additional inflammation is clinically preferable.
Step 6: Activation (Optional) Some protocols include activation of the PRP with calcium chloride or thrombin immediately before injection to trigger platelet degranulation and growth factor release at the injection site. Other protocols rely on the mechanical disruption of injection to trigger natural platelet activation in vivo. The choice depends on the specific application.
The PRP centrifuge at Rebuild Regen is operated according to validated protocols optimized for consistent 5x to 10x platelet concentration. The exact concentration achieved varies based on the patient's baseline platelet count and hematocrit. A complete blood count (CBC) is used to estimate the expected yield.
Conditions Treated With PRP: 8 Primary Applications
Platelet-rich plasma therapy at Rebuild Regen addresses eight primary clinical applications. Each draws on a different aspect of the PRP growth factor mechanism.
1. Knee Osteoarthritis
Intra-articular PRP injection is among the best-studied PRP applications. Multiple randomized controlled trials have compared PRP to hyaluronic acid injection and corticosteroid injection for knee OA, with PRP showing superior outcomes on pain scores and function measures at 6 and 12 months in mild to moderate disease. The protocol at Rebuild Regen typically uses leukocyte-poor PRP for intra-articular knee injection to minimize additional synovial inflammation while maximizing growth factor delivery to the cartilage and synovial environment.
2. Shoulder Conditions
Rotator cuff tendinopathy, partial tears, and glenohumeral OA respond to PRP injection. The subacromial space, bicipital tendon, and intra-articular glenohumeral joint are the specific injection targets depending on the pathology identified. Ultrasound guidance is used for precision placement. Patients recovering from arthroscopic rotator cuff repair sometimes receive PRP at the repair site to support tendon healing.
3. Hip Osteoarthritis and Hip Flexor Conditions
Intra-articular hip PRP injection requires fluoroscopic or ultrasound guidance due to the depth of the joint. At Rebuild Regen, imaging guidance is used for hip joint injections to ensure accurate product placement. Hip flexor and iliotibial band conditions are treated with targeted soft tissue injection.
4. Achilles Tendinopathy and Plantar Fasciitis
Chronic Achilles tendinopathy and plantar fasciitis are among the most well-documented PRP applications in the orthopedic literature. Both conditions involve chronic degeneration of collagen-rich tissue with inadequate healing response. PRP growth factors, specifically TGF-beta and PDGF, directly stimulate tenocyte activity and collagen synthesis. At Rebuild Regen, PRP for Achilles and plantar fascia conditions is frequently combined with Chattanooga Intelect RPW 2 shockwave therapy, creating a synergistic protocol.
5. Lateral Epicondylitis (Tennis Elbow) and Medial Epicondylitis
Chronic elbow tendinopathies affecting the common extensor or common flexor origin respond well to PRP injection. Studies comparing PRP to corticosteroid for lateral epicondylitis show PRP producing more durable outcomes at 12 months, while corticosteroid shows faster early relief but higher recurrence rates. PRP's collagen-stimulating mechanism addresses the underlying tendinosis rather than simply reducing pain signals.
6. Hair Restoration (Scalp PRP)
Platelet-rich plasma injections to the scalp stimulate hair follicle activity via growth factor delivery, particularly PDGF and VEGF, which promote follicular vascularity and cell proliferation. Scalp PRP is used for androgenic alopecia and diffuse thinning. Protocols typically involve 3 initial sessions spaced 4 to 6 weeks apart, followed by maintenance every 6 months. Results are progressive, with noticeable improvement in hair density and thickness typically seen at 3 to 6 months.
7. Sexual Wellness: P-Shot (Priapus Shot) and O-Shot
The P-Shot and O-Shot use PRP delivered to specific anatomical targets to improve sexual function. The P-Shot, for men, involves PRP injection into the corpus cavernosum and surrounding tissue to support erectile function via vascularity improvement and tissue health restoration. The O-Shot, for women, delivers PRP to the clitoral and vaginal tissue to address arousal, sensitivity, and urinary stress incontinence. Both protocols are outpatient procedures with no downtime.
8. Facial Rejuvenation
PRP is used in aesthetic facial applications, either combined with micro-needling (the "vampire facial" protocol) or as standalone intradermal injection. Growth factor delivery to the dermal layer stimulates collagen synthesis, improves skin texture, reduces fine lines, and supports post-procedure healing following laser or resurfacing treatments.
Who Is a Candidate for PRP Therapy
Platelet-rich plasma therapy is appropriate for a broad population. The autologous sourcing eliminates several of the candidacy concerns associated with biologic products.
Strong candidates include:
- Patients with early to moderate osteoarthritis (knee, hip, shoulder) who have not achieved adequate relief from conservative measures
- Athletes and active adults with tendinopathy, ligament sprains, or muscle injuries
- Patients with chronic tendon conditions (Achilles, plantar fascia, elbow) that have been unresponsive to physical therapy
- Patients experiencing hair thinning with active follicle population (early to moderate alopecia)
- Patients seeking non-surgical orthopedic intervention before considering joint replacement
- Patients with sexual health concerns appropriate for P-Shot or O-Shot protocols
- Aesthetic candidates seeking collagen-stimulating skin rejuvenation
Relative considerations affecting PRP candidacy:
- Anemia or low baseline platelet count: The yield of growth factors from PRP depends on the patient's starting platelet count. Patients with thrombocytopenia (low platelets) or anemia produce a lower-quality PRP concentrate. A CBC is reviewed before protocol initiation.
- Active anticoagulation therapy: Medications like warfarin or newer anticoagulants must be evaluated before PRP. Many patients can temporarily adjust their medication under physician guidance; others require a modified protocol.
- Severe end-stage joint disease: For Kellgren-Lawrence Grade IV OA with major structural compromise, PRP addresses the inflammatory component but cannot restore structural integrity. The consultation is honest about this limitation.
- Active infection at the target site: PRP introduces growth factors that could exacerbate local infection. Active skin or joint infection is a contraindication for injection at that site.
What to Expect: 6 Steps From Blood Draw to Recovery
Step 1: Consultation and Protocol Design
Elizabeth Celestin reviews the patient's condition, imaging results, treatment history, and goals. She determines the target site, appropriate PRP preparation (L-PRP vs. P-PRP, activation method), and whether PRP is recommended as a standalone treatment or combined with other modalities.
Step 2: Pre-Procedure Preparation
Patients are asked to:
- Hydrate well before the appointment (improves blood draw quality)
- Avoid NSAIDs and aspirin for 7 to 10 days before the procedure (these inhibit platelet function and blunt the PRP response)
- Eat normally on the day of the procedure
No sedation or fasting is required.
Step 3: Blood Draw
Venous blood is drawn from the patient's arm. The volume drawn depends on the protocol, typically 20 to 40 mL for most orthopedic applications, up to 60 mL for larger protocols or when multiple sites are being treated in the same session. The draw takes 5 to 10 minutes.
Step 4: PRP Processing
The drawn blood is processed through the centrifuge protocol. Total processing time is typically 15 to 20 minutes. During this time, the patient rests comfortably. The provider inspects the resulting PRP product for appropriate separation and concentration.
Step 5: Injection
The target site is prepared with topical anesthetic or local block as appropriate. The PRP product is administered via injection to the treatment site. Precision guidance (ultrasound or fluoroscopic) is used for deep joint injections. Procedure time for the injection itself is typically 5 to 15 minutes.
Most patients experience moderate discomfort during injection at musculoskeletal sites. Intra-articular injections produce a brief pressure sensation. Tendon injections are more uncomfortable due to the tissue density.
Step 6: Recovery and Post-Procedure Period
Immediately after the procedure:
- The treated area may be more sore for 24 to 72 hours as the PRP activates and initiates the inflammatory repair cascade. This discomfort is expected and is a sign of biological activity.
- Ice is not used on the treated area post-PRP. Ice suppresses the inflammatory signal that PRP is specifically designed to trigger.
- NSAIDs are restricted for 1 to 2 weeks post-procedure for the same reason.
- Activity modification varies by treatment site. Joint injections typically call for reduced weight-bearing and impact activities for 48 to 72 hours. Return to sport is typically guided at 2 to 6 weeks.
Results and Realistic Expectations
Platelet-rich plasma therapy produces results over a timeline that reflects biological tissue repair, not pharmaceutical pain suppression. Understanding this timeline is essential to realistic expectations.
Typical timeline by application:
Orthopedic (OA, tendinopathy, ligament):
- Weeks 1 to 2: Increased soreness in some patients as the repair cascade activates
- Weeks 3 to 6: Initial improvements in pain levels and function begin
- Months 2 to 3: Clearest improvement window for most orthopedic patients
- Months 3 to 6: Response consolidation. Many patients achieve 50 to 70 percent reduction in pain scores at 6 months for knee OA.
- Durability: PRP results in joint and tendon applications typically last 9 to 18 months. Repeat injection is appropriate when symptoms return.
Hair restoration:
- Month 1 to 2: Minimal visible change; biology is active at follicle level
- Month 3: Initial improvement in density and reduced shedding
- Month 4 to 6: Most visible results. Continued improvement through initial 3-session series.
- Maintenance: Every 6 months for sustained results
Aesthetic (facial):
- Weeks 2 to 4: Skin quality and texture improvements begin
- Month 2 to 3: Collagen remodeling produces visible improvements in fine lines and tone
- Maintenance: Every 6 to 12 months
Number of sessions:
- Many orthopedic conditions respond to a single PRP injection. Repeat injection at 6 to 12 week intervals is common for tendinopathy.
- Hair restoration uses a series of 3 initial treatments.
- The treating provider discusses the expected session number at consultation based on the specific condition and severity.
Costs and What Is Included
PRP therapy pricing varies based on the specific protocol, injection site, and whether PRP is administered as a standalone treatment or as part of a combined biologic protocol.
PRP is among the more accessible regenerative medicine options at Rebuild Regen. Pricing reflects the procedure time, product processing, and provider expertise rather than expensive biologics costs, since the product is derived from the patient's own blood.
Exact pricing is provided at consultation. All pricing is transparent and agreed upon before any procedure is scheduled.
What is included:
- Elizabeth Celestin consultation and protocol design
- Blood draw and centrifuge processing
- Injection procedure with appropriate guidance
- Post-procedure instructions and follow-up scheduling
Insurance does not cover PRP for most applications. Medical financing is available.
The Rebuild Regen Approach to PRP
Rebuild Regen Medical Clinic's approach to PRP is defined by two commitments: clinical precision and honest protocol positioning.
Clinical precision means using the appropriate PRP preparation for the specific application. Elizabeth Celestin selects leukocyte-rich or leukocyte-poor PRP based on the tissue target. She uses imaging guidance for deep joint injections where blind placement produces inferior results. She adjusts centrifuge protocols to optimize platelet yield for each patient's baseline blood count.
Honest protocol positioning means being straightforward about when PRP is the right primary intervention and when the condition warrants a stronger biologic. PRP is an excellent first-line regenerative option for many orthopedic, hair restoration, and aesthetic applications. For patients with more advanced degeneration, significant systemic inflammation, or conditions that have already failed PRP, the conversation moves toward DayZero™ exosome therapy, DayZero™ stem cell therapy, or combination protocols.
PRP is also frequently used as a component of combination protocols with DayZero™ biologics. DayZero™ MSCs or exosomes delivered alongside PRP at the same injection site create a synergistic environment: PRP provides the local growth factor boost from the patient's own blood while the DayZero™ product adds the perinatal tissue signaling components not available autologously.
Is PRP the Right Starting Point or Is a Biologic Upgrade Needed?
The question of whether PRP is sufficient or whether a more advanced biologic is indicated depends on three factors: the severity of the condition, the history of prior treatments, and the patient's goals.
PRP as a strong starting point:
- First-line regenerative treatment for mild to moderate OA
- First-line for tendinopathy and soft tissue injuries
- Appropriate for hair restoration as an initial protocol
- Preferred when autologous sourcing is a patient priority
- Lower cost entry point for regenerative medicine with a strong evidence base
Indicators that a biologic upgrade is appropriate:
- Prior PRP treatment that produced limited or short-lived results
- Moderate to severe OA where the cartilage loss exceeds what PRP growth factors can adequately address
- Significant neurological or systemic inflammatory component that requires the broader signaling toolkit of MSCs or exosomes
- Conditions spanning multiple body systems where systemic IV delivery is more appropriate than localized injection
- Patient with baseline platelet abnormalities that limit PRP yield
The consultation at Rebuild Regen addresses this question directly. Elizabeth Celestin explains why a given protocol is recommended and what the clinical rationale is for starting with PRP versus going directly to a more advanced biologic. There is no financial incentive driving recommendations toward higher-cost treatments; the goal is the right intervention for each individual patient.
Frequently Asked Questions
How long does PRP take to work?
PRP therapy initiates a biological repair process. Initial improvements in pain and function are typically seen between weeks 3 and 6. The most significant response for orthopedic applications usually occurs at 2 to 3 months. The biological cascade activated by PRP growth factors takes time to produce visible tissue changes.
How many PRP sessions do I need?
The number of sessions depends on the condition being treated. Many orthopedic applications respond to a single injection, with repeat treatment at 6 to 12 months if symptoms return. Tendinopathy conditions often benefit from 2 to 3 sessions spaced 6 weeks apart. Hair restoration uses a standard initial series of 3 sessions. The treating provider discusses expected session count at consultation.
Is PRP better than cortisone injections?
PRP and corticosteroid injections serve different purposes. Corticosteroid produces faster pain relief by suppressing inflammation directly. PRP works more slowly by initiating the repair process. The key difference is durability: studies comparing PRP and corticosteroid for knee OA and lateral epicondylitis show PRP producing better outcomes at 12 months, while corticosteroid's effect diminishes after 3 to 6 months. PRP addresses the biology driving the condition; corticosteroid manages the symptom.
Does PRP hurt?
PRP injection causes discomfort at the injection site. The level of discomfort varies by location. Superficial injections (scalp, skin) are minimal. Tendon injections are more uncomfortable due to tissue density. Intra-articular injections produce a pressure sensation inside the joint. Topical anesthetic and local blocks are used to manage procedural discomfort. Post-procedure soreness for 24 to 72 hours is expected and is part of the normal biological response.
Can PRP treat arthritis?
PRP therapy is one of the most well-studied treatments for knee osteoarthritis, with multiple randomized controlled trials demonstrating superiority over hyaluronic acid and corticosteroid at 6 to 12 months. PRP addresses the inflammatory environment and supports cartilage cell health. It does not reverse established cartilage loss. For mild to moderate OA, PRP is a strong evidence-based intervention. For severe structural OA, the conversation includes whether stem cell therapy or mechanical joint support is more appropriate.
How is Rebuild Regen's PRP different from other providers?
The centrifuge protocol and provider expertise determine PRP quality. Rebuild Regen uses validated processing protocols optimized for consistent 5x to 10x platelet concentration. Elizabeth Celestin determines leukocyte-rich versus leukocyte-poor preparation based on the specific tissue target. Imaging guidance is used for deep joint injections. The clinic does not use "one kit fits all" PRP processing; the protocol is adapted to the clinical application and patient's blood profile.
Can I get PRP if I am on blood thinners?
Anticoagulation therapy requires evaluation before PRP. Some medications can be temporarily paused under physician guidance for the pre-procedure window. Others cannot be safely interrupted. The consultation with Elizabeth Celestin reviews the patient's full medication list, consults with the prescribing physician if needed, and determines whether PRP is feasible and safe given the anticoagulation context.
How long do PRP results last?
For orthopedic applications, PRP results typically last 9 to 18 months. Durability depends on the underlying condition's severity, the patient's activity level, and whether lifestyle factors support the repair environment initiated by PRP. Hair restoration results are maintained with 6-month maintenance sessions. Aesthetic results typically last 9 to 12 months.
Can PRP and stem cell therapy be done together?
PRP and DayZero™ stem cell therapy or exosome therapy are frequently combined at Rebuild Regen. PRP delivered at the same injection site as DayZero™ MSCs or exosomes creates a synergistic environment: the autologous growth factors from PRP and the perinatal tissue signaling from the DayZero™ product work together to create a more comprehensive repair signal than either alone.
When PRP Is Insufficient and a Stronger Biologic Is Indicated
Platelet-rich plasma therapy is an effective and evidence-supported regenerative intervention, but it reaches the limits of its utility in specific clinical contexts.
Advanced structural degeneration: PRP growth factors stimulate repair signals, but when joint degeneration has progressed to severe bone-on-bone OA or near-complete tendon rupture, the structural deficit exceeds what PRP can address. Patients in this category benefit from a consultation that honestly addresses whether PRP is the right intervention or whether DayZero™ stem cell therapy, mechanical decompression, or surgical evaluation is more appropriate.
Systemic inflammatory conditions: PRP is a local intervention. It delivers growth factors at the injection site and produces local biological effects. Conditions driven by systemic inflammation, including generalized neuropathy, autoimmune-adjacent arthritis affecting multiple joints, or chronic fatigue associated with high inflammatory burden, are better addressed by systemic IV biologics including DayZero™ MSCs or DayZero™ exosomes, which can be delivered IV to reach multiple tissue targets simultaneously.
Prior PRP treatment with inadequate response: When a patient has received two or more rounds of PRP at appropriate intervals without adequate response, this is a signal that the condition requires a more powerful biologic. The next step in the protocol hierarchy is typically DayZero™ exosome therapy at the 150B to 250B level, followed by DayZero™ stem cell therapy if the exosome response is also insufficient.
Low platelet baseline: Patients with thrombocytopenia or conditions that limit platelet production will not produce PRP of sufficient concentration for a therapeutic effect. In these cases, allogeneic biologics (DayZero™ MSCs or exosomes) provide the regenerative signal that the patient's own blood cannot supply.
The honest conversation about PRP's limitations is as important as the case for its use. Elizabeth Celestin explains clearly when PRP is the right starting point and when it is time to step up the protocol.
Schedule a consultation: (954) 953-4208 | Rebuild Regen Medical Clinic, 3320 N Federal Hwy #101, Lighthouse Point, FL 33064.
Ready to start your recovery?
Schedule a consultation at Rebuild Regen Medical Clinic in Lighthouse Point, FL.